Bajaj HealthCare Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Bajaj HealthCare Limited generated cash of $922,944,000, which is more than the previous year. Cash used in financing activities reached the amount of -$547,200,000 last year. Net change in cash is therefore -$155,457,000.
Cash Flow
| 2012 | 85.91M | -145.15M | 63.56M |
|---|---|---|---|
| 2016 | 251.37M | -306.65M | 50.82M |
| 2018 | 166.14M | -116.37M | 24.69M |
| 2020 | 205.74M | -275.60M | 32.82M |
| 2021 | 435.58M | -1.08B | 754.57M |
| 2023 | -223.23M | -934.26M | 1.31B |
| 2024 | 922.94M | -112.44M | -547.2M |
BAJAJHCARE.NS Cash Flow Statement (2012 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2012 | |
|---|---|---|---|---|---|---|---|
Cash at beginning of period | 177.20M | 19.75M | 41.58M | 78.61M | 8.39M | 8.69M | 1.15M |
Operating activities | |||||||
Net income | -143.26M | 582.16M | 1.18B | 324.51M | 226.84M | 134.98M | 6.50M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||
Depreciation and amortization | 314.47M | 273.55M | 161.24M | 121.23M | 110.83M | 92.89M | 56.08M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||
Accounts receivable, net | 125.96M | -474.24M | 3.51M | -220.05M | -276.98M | 85.70M | 0 |
Inventories | 204.20M | -495.24M | -578.35M | -92.27M | -168.99M | -15.58M | 19.28M |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 922.94M | -223.23M | 435.58M | 205.74M | 166.14M | 251.37M | 85.91M |
Investing activities | |||||||
Purchases Of Investments | 0 | 0 | -1.89M | -50M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -302.86M | -1.23B | -1.13B | -226.89M | -97.70M | -306.74M | -171.22M |
Acquisitions Net | 0 | 307.74M | 1.89M | 974K | 0 | 2.43M | 0 |
Cash generated by investing activities | -112.44M | -934.26M | -1.08B | -275.60M | -116.37M | -306.65M | -145.15M |
Financing activities | |||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -27.59M | -41.39M | -24.14M | 0 | 0 | 0 | -2.62M |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -15M | 0 |
Repayments of term debt | -517.29M | 451.59M | -861.68M | 61.85M | 116.92M | 92.29M | 0 |
Cash used in financing activities | -547.2M | 1.31B | 754.57M | 32.82M | 24.69M | 50.82M | 63.56M |
Net Change In Cash | -155.45M | 157.45M | 100.82M | -37.03M | 74.45M | -4.44M | 4.32M |
Cash at end of period | 21.74M | 177.20M | 142.41M | 41.58M | 82.85M | 4.24M | 5.47M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |